Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
about
Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophagesLatent reservoirs of HIV: obstacles to the eradication of virusTargeted DNA mutagenesis for the cure of chronic viral infectionsT cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?Developing Combined HIV Vaccine Strategies for a Functional CureTranscriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cureContribution of HIV-1 genomes that do not integrate to the basic reproductive ratio of the virus.Large Variations in HIV-1 Viral Load Explained by Shifting-Mosaic Metapopulation DynamicsDepletion of latent HIV-1 infection in vivo: a proof-of-concept studyThe thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitroTargeted killing of virally infected cells by radiolabeled antibodies to viral proteinsAn "escape clock" for estimating the turnover of SIV DNA in resting CD4⁺ T cellsModeling of HIV-1 infection: insights to the role of monocytes/macrophages, latently infected T4 cells, and HAART regimesPhosphorylation of CDK9 at Ser175 enhances HIV transcription and is a marker of activated P-TEFb in CD4(+) T lymphocytesResidual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolutionResidual Viremia in Treated HIV+ IndividualsPredicting the outcomes of treatment to eradicate the latent reservoir for HIV-1Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNAShort-Sighted Virus Evolution and a Germline Hypothesis for Chronic Viral Infections.Eradication therapies for HIV Infection: time to begin again.HIVed, a knowledgebase for differentially expressed human genes and proteins during HIV infection, replication and latency.Human immunodeficiency virus vaccine trialsLessons from acute HIV infection.Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cellsBeneficial effect of TRAIL on HIV burden, without detectable immune consequences.Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi babyThe detection and management of early HIV infection: a clinical and public health emergency.Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure.Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.Protection against establishment of retroviral persistence by vaccination with a live attenuated virus.Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulationFrequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designsAdvancements in Developing Strategies for Sterilizing and Functional HIV Cures.Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA.A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
P2860
Q21135536-B0DEC991-7BE2-4D0A-B778-6EECAB8E150BQ24615570-E2535AA5-C5F4-407A-91DD-4A341F0554F8Q24620150-2C7268FA-9A9D-4598-850F-16ACA4EB2DEDQ24627662-E99F05D5-101A-461B-BC41-FA36CF083D21Q26822422-F96B5DE6-C76A-4050-AFFE-C6BC8CBB7082Q26998898-3131DCF7-0A36-46F6-999D-3741B77C6FC9Q26999858-AD6D4F75-6573-4EE3-B084-275D706F47CDQ27309008-8C1921D8-10FF-4710-BA5C-39FD9309E3A8Q27339956-61B6C85E-B4AF-4CB1-A6EC-529915571B3EQ28111910-CF268F51-3FD8-497F-92A2-B131F94FAC36Q28343837-D81A4435-61A1-4DCB-B25F-5D7CBC3AD09FQ28469068-20A7CE4C-167C-444E-8C5E-104910015718Q28482134-29FC871D-3138-49CA-80CE-2B57446ACB51Q28484046-F9D15329-28D6-44B2-A6FF-5C5F7EBDA619Q28487524-0A227F11-D795-418D-A1FE-8EFE123E00ABQ28539563-C168B092-C6BA-4A9F-BC9F-6D0A6E5C8C2EQ28552126-4D83EF2A-9619-4A5E-8FDB-A76BCAC21ED7Q28655602-B776E786-1CF3-4BE7-83E0-2C7F1DCE8172Q28731610-5EEA490F-79BB-44E6-B5EC-34724745B421Q30234948-3A9A2F2D-C624-4219-B1BA-5284F2C1A73BQ30399588-0E44981F-1662-4592-A686-DBA428B182C8Q30400491-E1F2BB7D-59E7-4665-BC13-B8CB8DB7EC59Q30424366-FFF5BB05-47C2-45B0-B085-32DDAEFA6BD8Q30490195-092D0C5D-A09C-425A-A1F6-8F375AA2B424Q33285471-6164DFAF-3F34-48CD-BB44-85C118B5B568Q33366417-803F5D18-CE5F-444B-BE0E-40525567B2B9Q33378492-1343DA6A-A8A5-4AAC-89FD-E5BA6287A5D5Q33513977-2B475CBB-5591-4FFD-8C90-89ADFE2AFD94Q33557037-1EC8A92F-5E75-4A26-A2F4-A274484F552AQ33586581-AF9DC7B3-AA40-49D3-9689-EB62ECE5727FQ33593633-38B12863-AE56-4008-AF20-B93329B9AC84Q33611645-8E7B3001-80F6-4AB9-BF14-2A0337092470Q33644248-1C87152C-A173-4F27-A5DA-7BBA9BA46313Q33646493-726B75DD-E915-4246-89FC-0D4DA391C4A5Q33649801-87B33F9C-2562-438E-984A-9C19E36B37F6Q33652911-B97EF12D-F096-4618-8DE2-E254549CEFDAQ33654409-67E80D5C-F291-46CF-8348-459E048C701AQ33693987-3E5E07A1-D6F2-4612-85CF-9590B26CFA9AQ33724206-C90F8B76-15E6-49DA-B22D-712C588F686BQ33724247-134EC448-74C4-496C-A997-54D180A50CE6
P2860
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Early establishment of a pool ...... uring primary HIV-1 infection.
@ast
Early establishment of a pool ...... uring primary HIV-1 infection.
@en
type
label
Early establishment of a pool ...... uring primary HIV-1 infection.
@ast
Early establishment of a pool ...... uring primary HIV-1 infection.
@en
prefLabel
Early establishment of a pool ...... uring primary HIV-1 infection.
@ast
Early establishment of a pool ...... uring primary HIV-1 infection.
@en
P2093
P2860
P356
P1476
Early establishment of a pool ...... uring primary HIV-1 infection.
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.15.8869
P407
P577
1998-07-01T00:00:00Z